Abstract
Prostate cancer (Ca P), the most commonly diagnosed male cancer, will be a health care issue that will have a significant impact on the American health care system as the population of the United States continues to age. It is anticipated that the number of men diagnosed with Ca P will continue to increase each year. Screening, diagnosis, and treatment modalities for Ca P in men over 65 years of age are discussed.
MeSH terms
-
Adult
-
Age Distribution
-
Aged
-
Antineoplastic Agents / therapeutic use
-
Cryosurgery
-
Gonadotropin-Releasing Hormone / agonists
-
Humans
-
Male
-
Mass Screening / methods
-
Middle Aged
-
Neoplasm Staging / methods
-
Nurse's Role
-
Orchiectomy
-
Patient Education as Topic
-
Prostate-Specific Antigen / blood
-
Prostatectomy
-
Prostatic Neoplasms* / diagnosis
-
Prostatic Neoplasms* / epidemiology
-
Prostatic Neoplasms* / etiology
-
Prostatic Neoplasms* / therapy
-
Radiotherapy
-
Risk Factors
-
United States / epidemiology
Substances
-
Antineoplastic Agents
-
Gonadotropin-Releasing Hormone
-
Prostate-Specific Antigen